Get this right and everything else becomes substantially easier
- Sueo: Mejora la calidad del sueo
For patients with type 2 diabetes, the American Diabetes Association (ADA) Standards of Care emphasize individualized glycemic targets and treatment selection based on patient-specific factors including baseline hemoglobin A1c (HbA1c), presence of atherosclerotic cardiovascular disease (ASCVD), heart failure, or chronic kidney disease, hypoglycemia risk, weight considerations, and patient preferences
Weight Loss Service Start your weight loss journey with professional support from Chemist Click Check Eligibility In clinical trials, the amount of weight lost depended on the dose, how long treatment was taken for, and the type of patient included in the study
Long-term follow-up in the DPPOS showed that adherent metformin users maintained roughly 6.2% weight loss below baseline after 15 years, demonstrating durable but modest results particularly in individuals with insulin resistance and higher BMI